# EUS-FNB With ROSE Vs. EUS-FNB Without ROSE

> **NCT03322592** · NA · COMPLETED · sponsor: **Azienda Ospedaliera Universitaria Integrata Verona** · enrollment: 800 (actual)

## Conditions studied

- Biopsy, Fine-needle
- Pancreatic Neoplasm

## Interventions

- **DIAGNOSTIC_TEST:** Rapid on-site evaluation (ROSE)
- **DIAGNOSTIC_TEST:** Histologic evaluation

## Key facts

- **NCT ID:** NCT03322592
- **Lead sponsor:** Azienda Ospedaliera Universitaria Integrata Verona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-29
- **Primary completion:** 2019-12-13
- **Final completion:** 2020-07-30
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2020-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03322592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03322592, "EUS-FNB With ROSE Vs. EUS-FNB Without ROSE". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03322592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*